Primary human xenografts are human cancer tissues which are xenotransplanted into immunodeficient mice. Numerous studies have demonstrated that these xenografts much more closely resemble primary human cancers at the histological and molecular level then do xenografts generated from cell lines propagated in vitro (f-3). Primary xenograft models have proven most valuable in studying tumor biology and cellular heterogeneity, as well as for evaluating the efficacy of therapeutic agents. A prime example of the utility of primary human xenografts has been In the identification and characterization of human cancer stem cells (CSCs). UMCCC investigators used these models to report the Initial identification of CSCs in cancers of the breast, pancreas, head and neck and ovaries (4-6). Subsequently, xenograft models have been utilized by other UMCCC investigators to investigate CSCs in the brain, liver, adrenal and lung cancers {9-11). In addition to identifying CSC populations In various tumor types, these models have proven invaluable in studying the pathways which regulate them and in developing CSC-based therapeutics. Indeed, agents targeting CSCs regulatory pathways including Notch, Hedgehog, HER2/Akt, Wnt and cytokine signaling are being evaluated In multiple tumor types by UMCCC investigators. These preclinical studies have already led to the development of several early stage clinical trials targeting these CSC pathways. An important component of the translational oncology research strategy involves the development and testing of molecular targeted therapeutics In these xenograft models.

Public Health Relevance

The Primary Tumor Xenograft Core will establish individual patient tumors in mice to allow the study of individual patient tumors lo best design personalized therapeutics. A broad range of tumors will be analyzed.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Ann Arbor
United States
Zip Code
Skolarus, Ted A; Metreger, Tabitha; Hwang, Soohyun et al. (2017) Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials 18:181
Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668
Pinskey, Justine M; Franks, Nicole E; McMellen, Alexandra N et al. (2017) Neuropilin-1 promotes Hedgehog signaling through a novel cytoplasmic motif. J Biol Chem 292:15192-15204
Maj, Tomasz; Wang, Wei; Crespo, Joel et al. (2017) Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol 18:1332-1341
Zhang, Jie; Feng, Shumei; Su, Wenmei et al. (2017) Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Sci Rep 7:42819
Mann, J E; Hoesli, R; Michmerhuizen, N L et al. (2017) Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC. J Cancer 8:332-344
Birkeland, Andrew C; Foltin, Susan K; Michmerhuizen, Nicole L et al. (2017) Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. Oral Oncol 68:5-8
Walline, Heather M; Goudsmit, Christine M; McHugh, Jonathan B et al. (2017) Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. Head Neck 39:840-852
Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2017) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res 15:179-188
VAN Noord, Raelene A; Thomas, Tina; Krook, Melanie et al. (2017) Tissue-directed Implantation Using Ultrasound Visualization for Development of Biologically Relevant Metastatic Tumor Xenografts. In Vivo 31:779-791

Showing the most recent 10 out of 1355 publications